Novartis Says 330 Jobs Hit as It Closes MorphoSys Sites

The Edge Markets17:20

European Stocks That Trade Cheaper Than U.S. Peers

Seeking Alpha03:39

Your Healthcare Costs Are Soaring! US Spending Reached $5 Trillion In 2023 With Major Increase in Obesity and Diabetes Drugs, Hospital Services

Benzinga02:38

Sanofi: Kress Was the CEO of MorphoSys From 2019 Until It Was Acquired by Novartis in 2024

Dow Jones01:06

Novartis will close MorphoSys's factories in Germany and the USA.

According to Reuters on December 19, the Swiss pharmaceutical group Novartis announced on Thursday that it will close the German Biotechnology company MorphoSys's factories in Germany and the USA, acquired earlier this year, affecting approximately 330 positions. A company spokesperson stated that the plan is to exit the factories in Munich and Boston by the end of 2025 and to consolidate all portfolio activities into Novartis.

Gelonghui FinanceDec 19 21:25

Market Chatter: Novartis to Close MorphoSys Sites, Affecting 330 Jobs

MT NewswiresDec 19 20:47